Has Michal Klek, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,231 in general payments to Michal Klek, MD across 56 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michal Klek, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michal Klek, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michal Klek, MD

Orthopaedic Surgery · Millsboro, DENPI 1790217313

Payments from drug & device makers

What this record shows

6 manufacturers reported payments, led by Medacta USA, Inc. at 56.4% of the total. Reporting peaked in 2023 at $2,844 and has fallen 89.5% since, to $298 in 2025.

$7,231in general payments, 2019–2025

Across 56 payments — averaging $129.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medacta USA, Inc.$4K
Stryker$3K
Zimmer Biomet$199
Johnson & Johnson$130
Heraeus Medical, LLC.$36
Medical Device Business Services, Inc.$30

What the payments were for

Travel & lodging$4,31860%
Food & beverage$2,91340%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medacta USA, Inc.	27	$4,082
Stryker	23	$2,754
Zimmer Biomet	2	$199
Johnson & Johnson	1	$130
Heraeus Medical, LLC.	2	$36
Medical Device Business Services, Inc.	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,231 in reported general payments places this provider in the 55th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware →

Medicare billing

Part B allowed, 2024

$261,055

Medicare patients

724

Services billed

5,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	158	$776
Cefadroxil	17	$260
Tramadol Hcl	74	$246
Oxycodone Hcl	31	$184
Methylprednisolone	21	$130
Gabapentin	19	$110
Amoxicillin	15	$15

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Millsboro

William DoranMillsboro$13K
Courtney CaputoMillsboro$1K
Suken ShahWilmington$2.1M
Jeremie AxeNewark$179K
Andrew CurleySeaford$70K
Patrick WardWilmington$68K
Patrick KaneLewes$68K
Kenneth LingenfelterNewark$67K
Drew BradyNewark$64K
Steven DelloseWilmington$52K

See the full list for Delaware →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →